DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Light-induced analgesia provides a drug-free optical method for pain relief via activation of TRAAK k+ channels
Pain management in animal experimentation is crucial for both ethical and scientific reasons, as unmanaged pain can distort physiological responses compromising data reliability. Current strategies are often invasive and pharmacology-based, introducing variability and confounding effects. Here, we present Light-Induced Analgesia, a drug-free, non-invasive method for pain relief in animals. We show that 365 nm illumination activates the pain-inhibitory TRAAK two-pore domain potassium (K2P) channel. This activation is driven by the oxidation of a native methionine at TRAAK's regulatory fenestration site, triggering a conformational switch from its inactive (down) to active (up) state. We further demonstrate that this mechanism can be transferred to other related K2Ps via a single-point mutation, rendering them light-sensitive. In rodents, gentle skin exposure to 365 nm is sufficient to activate endogenous TRAAK, silence nociceptors, and produce potent, long-lasting analgesia that outperforms standard treatments. Light-Induced Analgesia thus offers an effective, drug-free alternative that can enhance animal welfare and experimental reliability in preclinical research., The authors thank Brigitte Wdziekonski, Vanessa Roubeaud for their technical help, as well as Stéphane Supplisson, Dominique Debanne and Hélène Guizouarn for their insightful discussions and comments. This work was supported by grants to Guillaume Sandoz by the Fondation Simone et Cino del Ducas (Institut de France), Agence Nationale pour la Recherche (Rhodopsins, ANR-19-CE11-0026-01; Electro-Wnt, ANR-24-CE14-7899; HumASIC, ANR-22-CE16-0006), the Laboratory of Excellence “Ion Channel Science and Therapeutics” (grant ANR-11-LABX-0015-01), by the French government, through the France 2030 investment plan managed by the Agence Nationale de la Recherche, as part of the Université Côte d’Azur’s Initiative of Excellence (reference ANR-15-IDEX-01), by a grant to Johannes Broichhagen by European Union’s Horizon Europe Framework Programme (deuterON, grant agreement no. 101042046), by grants to Eric Boué-Grabot by Agence Nationale pour la Recherche (PurplePAIN, ANR-20-CE14-0016) and “Investments for the Future” programs of the University of Bordeaux’s IdEx program GPR BRAIN_2030, by a grant to Felix Viana by Ministerio de Ciencia e Innovación (GVA-PROMETEO/2021/03, PID2022-140961OB-I00, CEX2021-001165-S), and by a grant to Marion Bied by Fondation pour la recherche médicale (FDT202404018660)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
Proyecto:
EC / HE 101042046
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-140961OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 CEX2021-001165-S
DOI: http://hdl.handle.net/10261/420579, https://api.elsevier.com/content/abstract/scopus_id/105028449846
HANDLE: http://hdl.handle.net/10261/420579, https://api.elsevier.com/content/abstract/scopus_id/105028449846